M&A WATCH- EFG Hermes is reportedly looking to acquire a controlling stake in Bio Pharma Egypt by buying BPE Partners’ Midcap fund’s shares, sources told Al Mal. The transaction would be part of EFG Hermes’ merchant banking operations, the source says, suggesting the transaction would be warehoused for EFG’s Rx Healthcare Fund.
More from Enterprise
Banque du Caire’s blockbuster IPO holds firm against EGX selloff
The IFC and the EBRD are in for USD 100…
Electricity Ministry studies changing how your electricity bill gets calculated
The plan is still under study, and neither of the…
EGX30 sheds 4.43% in October to post its first back-to-back monthly loss of 2026
The benchmark fell 4.43% and the small caps twice as…
DPI closes Egypt-born fintech fund Nclude at USD 112 mn
The final close adds roughly USD 7 mn to a…